National Health Investors Inc expected to post earnings of 75 cents a share - Earnings Preview

National Health Investors

21/02/2025 21:27

* National Health Investors Inc  NHI.N   NHI  is expected
to show
a rise in quarterly revenue when it reports  results on February
25 for the period ending December 31 2024
    * The Murfreesboro Tennessee-based  company is expected to
report
a 4.0% increase in revenue to $82.672 million from $79.47
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data. (SAL is on Total Revenue basis)
    * ​LSEG's mean analyst estimate for National Health
Investors Inc
is for earnings of 75 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for National
Health
Investors Inc is $77.00​, above​ its last closing price
of $69.76. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  1.03        1.08       1.03      Missed  -4.5
 Jun. 30 2024  1.10        1.10       1.18      Beat    7.4
 Mar. 31 2024  1.05        1.06       1.12      Beat    5.7​
 Dec. 31 2023  1.07        1.07       1.09      Beat    1.7
 ​​Sep.        1.08        1.08       1.08      Met     0
 30 2023                                                
 Jun. 30 2023  1.08        1.08       1.06      Missed  -2.3​
 Mar. 31 2023  0.99        1.00       1.11      Beat    11.4
 Dec. 31 2022  1.09        1.09       0.85      Missed  -22.2
 This summary was machine generated February 21 at 21:27 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)